Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aentib Group is a private boutique advisory and investment firm rather than a drug-development biotech or pharmaceutical company. The firm works with founders, executives, investors, fund managers and governments on strategy, capital formation, partnerships, expansion, M&A, IPO preparation and other growth initiatives, with activity spanning healthcare, technology and related sectors. Its principals emphasize a long history of helping create, capitalize and advise private equity programs and companies, including in life sciences. While Aentib has healthcare and biotech exposure through its leadership and portfolio-related activities, it does not appear to operate a proprietary therapeutic pipeline of its own.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aentib Group.